Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where William H. Cooner is active.

Publication


Featured researches published by William H. Cooner.


The Journal of Urology | 1995

Prostate Cancer Clinical Guidelines Panel Summary Report on the Management of Clinically Localized Prostate Cancer

Richard G. Middleton; Ian M. Thompson; Mark S. Austenfeld; William H. Cooner; Roy J. Correa; Robert P. Gibbons; Harry C. Miller; Joseph E. Oesterling; Martin I. Resnick; Stephen R. Smalley; John H. Wasson

PURPOSE The American Urological Association convened the Prostate Cancer Clinical Guidelines Panel to analyze the literature regarding available methods for treating locally confined prostate cancer, and to make practice policy recommendations based on the treatment outcomes data insofar as the data permit. MATERIALS AND METHODS The panel searched the MEDLINE data base for all articles from 1966 to 1993 on stage T2 (B) prostate cancer and systematically analyzed outcomes data for radical prostatectomy, radiation therapy and surveillance as treatment alternatives. Outcomes considered most important were survival at 5, 10 and 15 years, progression at 5, 10 and 15 years, and treatment complications. RESULTS The panel found the outcomes data inadequate for valid comparisons of treatments. Differences were too great among treatment series with regard to such significant characteristics as age, tumor grade and pelvic lymph node status. The panel elected to display, in tabular form and graphically, the ranges in outcomes data reported for each treatment alternative. CONCLUSIONS In making its recommendations, the panel presented treatment alternatives as options, identifying the advantages and disadvantages of each, and recommended as a standard that patients with newly diagnosed, clinically localized prostate cancer should be informed of all commonly accepted treatment options.


The Journal of Urology | 1999

HAVE COMPLICATION RATES DECREASED AFTER TREATMENT FOR LOCALIZED PROSTATE CANCER

Ian M. Thompson; Richard G. Middleton; Scott A. Optenberg; Mark S. Austenfeld; Stephen R. Smalley; William H. Cooner; Roy J. Correa; Harry C. Miller; Joseph E. Oesterling; Martin I. Resnick; John H. Wasson; Claus G. Roehrborn

PURPOSE The American Urological Association Prostate Cancer Clinical Guidelines Panel reviewed 12,501 publications on prostate cancer from 1955 to 1992 to determine whether the complication rates of external beam radiation therapy, interstitial radiotherapy and radical prostatectomy have decreased. MATERIALS AND METHODS Complications reported in at least 6 series, study duration and sample sizes were extracted. Year specific study weighted mean patient ages and complication rates were computed. Regression analysis was performed of the study year on weighted mean patient age and complication rate. RESULTS Study year had a significant effect on mean patient age and rate of the majority of complications examined. Data indicated a gradual increase in study patient age and a simultaneous decrease in complications from 1960 to 1990. CONCLUSIONS Complication rates in the treatment of localized prostate cancer have decreased during the last 20 to 40 years. This decrease occurred despite evidence that the average age of treated patients had increased during the same period.


The Journal of Urology | 1985

Percutaneous Ultrasonic Lithotripsy in the Community Hospital

R. Bruce Bass; Jeff H. Beard; William H. Cooner; B.R. Mosley; Harry S. Pond; Charles L. Rutherford

A total of 38 patients underwent attempted percutaneous extraction of upper tract calculi with the Wolf nephroscope. A 1-day interval between radiological insertion of the guide wire and extraction of the stone with the patient under general anesthesia was used. Of the stones 87 per cent were removed successfully. Average operating and hospitalization times were 62 minutes and 9.9 days, respectively. Reduced morbidity and a shorter interval to return to work make this the procedure of choice in selected cases.


Journal of Endourology | 1989

Coordination of Urosonography and Prostate-Specific Antigen in the Diagnosis of Nonpalpable Prostate Cancer

William H. Cooner; B.R. Mosley; Charles L. Rutherford; Jeff H. Beard; Harry S. Pond; R. Bruce Bass; William J. Terry; Todd C. Igel


The Journal of Urology | 1960

Clinical Evaluation of Effect of Premarin on Bleeding During and Following Prostatic Surgery

William H. Cooner; Harry M. Burros


JAMA | 1958

ENURESIS DUE TO URETERAL ECTOPIA: REPORT OF A CASE

William H. Cooner; Harry M. Burros; Eduardo Canon


The Journal of Urology | 1994

Editorial: Prostate Cancer

William H. Cooner


The Journal of Urology | 1960

Cystic Lymphangioma of the Adrenal: A Case Report

William H. Cooner; Harry M. Burros; Antonio Yaldesdapena


Archive | 1995

Special Communications PROSTATE CANCER CLINICAL GUIDELINES PANEL SUMMARY REPORT ON THE MANAGEMENT OF CLINICALLY LOCALIZED PROSTATE CANCER

Richard G. Middleton; Ian M. Thompson; Mark S. Austenfeld; William H. Cooner; Roy J. Correa; Robert P. Gibbons; Harry C. Miller; Joseph E. Oesterling; Martin I. Resnick; Stephen R. Smalley; John H. Wasson


Journal of Endourology | 1992

Ultrasound-Guided Biopsy of the Prostate: When Is It Indicated?

William H. Cooner

Collaboration


Dive into the William H. Cooner's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Harry M. Burros

Hospital of the University of Pennsylvania

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Martin I. Resnick

Case Western Reserve University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Roy J. Correa

Virginia Mason Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge